Victory Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,219
Closed -$621K 2541
2025
Q2
$621K Sell
13,219
-419,732
-97% -$18.7M ﹤0.01% 2014
2025
Q1
$19.1M Sell
432,951
-181,972
-30% -$8.38M 0.02% 826
2024
Q4
$22.2M Sell
614,923
-14,464
-2% -$505K 0.02% 803
2024
Q3
$20.2M Buy
629,387
+103,404
+20% +$3.86M 0.02% 844
2024
Q2
$19.8M Buy
525,983
+18,652
+4% +$785K 0.02% 814
2024
Q1
$25M Buy
507,331
+137,964
+37% +$6.38M 0.02% 734
2023
Q4
$13.5M Buy
369,367
+328,127
+796% +$8.56M 0.01% 932
2023
Q3
$953K Buy
+41,240
New +$1.13M ﹤0.01% 1678
2023
Q2
Sell
-516,352
Closed -$13.3M 2600
2023
Q1
$13.3M Sell
516,352
-143,461
-22% -$4.19M 0.01% 936
2022
Q4
$17.2M Sell
659,813
-276,934
-30% -$6.82M 0.02% 830
2022
Q3
$26.7M Sell
936,747
-42,847
-4% -$1.23M 0.03% 683
2022
Q2
$24.1M Buy
979,594
+197,477
+25% +$7.22M 0.03% 746
2022
Q1
$44.1M Buy
782,117
+7,843
+1% +$449K 0.04% 580
2021
Q4
$48M Sell
774,274
-54,911
-7% -$3.63M 0.04% 580
2021
Q3
$52.6M Sell
829,185
-43,377
-5% -$3.34M 0.05% 531
2021
Q2
$71.9M Buy
872,562
+27,297
+3% +$2.07M 0.07% 395
2021
Q1
$62.2M Buy
845,265
+197,361
+30% +$15.5M 0.06% 445
2020
Q4
$47M Buy
647,904
+104,920
+19% +$6.75M 0.05% 542
2020
Q3
$25.9M Buy
542,984
+501,644
+1,213% +$21.4M 0.03% 681
2020
Q2
$1.74M Sell
41,340
-247,318
-86% -$8.8M ﹤0.01% 1482
2020
Q1
$7.79M Buy
288,658
+141,799
+97% +$4.62M 0.01% 1155
2019
Q4
$5.65M Sell
146,859
-28,141
-16% -$659K 0.01% 1149
2019
Q3
$3.79M Buy
+175,000
New +$4.14M ﹤0.01% 1245

Other funds holding SWTX